Article Text

Download PDFPDF
Would Lipophilic Statin Therapy as a Prognostic Factor Improve Survival in Patients With Uterine Cervical Cancer?
  1. Moo-Kon Song, PhD*,
  2. Byoung-Sub Shin, MD, PhD,
  3. Chung-Sik Ha and
  4. Won-Young Park
  1. * Departments of Hematology-Oncology,
  2. Obstetrics and Gynecology, and
  3. Pathology, Hanyang University Hanmaeum Changwon Hospital, Changwon, Korea.
  1. Address correspondence and reprint requests to Byoung-Sub Shin, MD, PhD, Department of Obstetrics and Gynecology, Hanyang University Hanmaeum Changwon Hospital, WoniDae-Ro 682 Rd, 21 Changwon 51497, Korea. E-mail: sbsshin69{at}


Objectives In vitro studies showed that lipophilic statins inhibit cell growth, adhesion, and invasion and induce apoptosis in cancer cell lines. In uterine cervical cancer, several important factors including age, stage, anemia, lymphovascular invasion, lymph node metastases, and parametrial spread were known to significantly predict survival. We investigated whether statin therapy as a prognostic factor would significantly predict survival in cervical cancer.

Methods Patients with stages IB to IV cervical cancer who received radical hysterectomy and/or para-aortic lymph node dissection were included. The statin-use group was identified as patients who were continuously prescribed with lipophilic statins from prediagnostic period of the cancer.

Results The baseline characteristics of both statin-use group and control group were comparable. During a median follow-up of 36.6 months, progression-free survival and overall survival of the statin-use group were significantly higher than the control group (P < 0.001 and P = 0.004, respectively). In multivariate analysis, the statin-use group had an independent prognostic significance compared with other prognostic factors (progression-free survival: hazards ratio = 0.062, 95% confidence interval = 0.008–0.517, P = 0.010; overall survival: hazards ratio = 0.098, 95% confidence interval = 0.041–0.459, P = 0.032).

Conclusions In the present study, continuous lipophilic statin therapy from the prediagnostic period of uterine cervical cancer could reflect favorable outcome, independently.

  • Cervical cancer
  • Statin
  • Body mass index
  • Survival

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • The authors declare no conflicts of interest.